Targeting Cancer Stem Cells with Differentiation Agents as an Alternative to Genotoxic Chemotherapy for the Treatment of Malignant Testicular Germ Cell Tumors is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0.406. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: S10RR023781
National Institutes of Health
Grant: F30 CA247458
New York State Stem Cell Science
Grant: C32571GG
National Institutes of Health
Grant: 1F30CA247458-01
The role of the DNA damage response in the development and therapeutic sensitivity of malignant testicular germ cell tumors.
National Institutes of Health
Grant: 1S10RR023781-01
Mark I Model 68 Gamma Irradiator
FWCI
0.60
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals